TB-500: Thymosin beta-4 research in animal models has a generally favorable safety profile, with the peptide appearing naturally in most mammalian tissues at physiological concentrations
The iron chelating agent deferoxamine reduces astrocyte damage, suggesting that improvements in astrocyte functionality are partly attributed to the inhibition of their ferroptosis (Lian and Stringer, 2004)
Across the positive trials, change was measured at 4 to 12 weeks of consistent daily use, never days
Review scope
These effects could theoretically contribute to improved tissue recovery in the gastrointestinal tract
As we age, factors such as stress, environmental toxins, and poor nutrition can deplete our bodys glutathione levels, leading to oxidative stress and potential skin issues